NCT05601115

Brief Summary

RAT is an innovative approach that includes intensive, repeatable, interactive and personalized applications.The aim of tihis study is to investigate the effect of robotic hand therapy added to conventional rehabilitation on rehabilitation outcomes in stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

1.4 years

First QC Date

October 18, 2022

Last Update Submit

July 19, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Brunnstrom stage

    Brunnstrom Staging is a test that evaluates the motor development of hemiplegic patients. In this test, the neurophysiological recovery process of the hemiplegic patient was defined as 6 stages. According to this staging low stage; stage 1 (flask, the stage without voluntary movement), the highest stage was determined as stage 6 (stage with isolated joint movement). Hand, upper and lower limbs in Brunnstrom staging extremities are evaluated separately.

    5 minutes

  • upper extremity spasticity assessment

    It was planned to evaluate spasticity with the Modified Ashworth Scale (MAS). In MAS, patients are evaluated over 5 points. 0; there is no increase in muscle tone, and 4 indicates that the extremity is rigid in the direction of flexion and extension.

    5 minutes

  • Fugl Meyer Upper Extremity Assessment Questionnaire wrist and hand assessment

    The Fugl-Meyer Upper Extremity Motor Rating Scale was developed to quantitatively evaluate sensorimotor recovery after stroke.Based on Brunnstrom's stages of motor recovery

    15 minutes

  • ABILHAND Stroke Hand Function Questionnaire

    The ABILHAND Hand Questionnaire was developed in 1998 to measure patient-perceived dexterity. It contains 23 questions about how difficult the patient has to do the activities. impossible (0 points), difficult (1 point), easly (2 points) options is marked. The total score is 46.

    15 minutes

Secondary Outcomes (4)

  • Functional Independence Scale

    20 minutes

  • Stroke Impact Survey

    20 minutes

  • Stroke Specific Quality of Life Scale: SSQOL

    30 minutes

  • short form 36

    30 minutes

Study Arms (2)

Robot Assisted Therapy Group

EXPERIMENTAL

In addition to the conventional treatment for 60 minutes in the Robot asisted therapy (RAT) group, it was planned to perform robotic rehabilitation with a hand-finger robot \[Amadeo (Tyromotion, Graz, Austria)\] for 30 minutes, accompanied by a physiotherapist who is trained in the field of robotic rehabilitation and has at least 5 years of experience. For the purpose of conventional therapy, an exercise program consisting of 45 minutes of range of motion exercises, strengthening exercises, balance exercises and neurophysiological exercises (Brunstroom exercises) accompanied by a physiotherapist experienced in stroke rehabilitation for at least 5 years, and neuromuscular therapy for the upper and lower extremities for 15 minutes.Electrical stimulation (NMES) application was planned. It was planned to apply a total of 60 sessions of treatment 5 days a week to both groups. They will be advised to continue the medical treatment they have been using during the treatment program.

Procedure: Robot assisted therapy

Conventional Therapy Group

ACTIVE COMPARATOR

45 minutes of range of motion exercises, strengthening exercises, balance exercises and neurophysiological studies were performed in the presence of a physiotherapist experienced in stroke rehabilitation for at least 5 years.An exercise program consisting of exercises (Brunstroom exercises) and 15 minutes of NMES were planned. It was planned to apply a total of 60 sessions of treatment 5 days a week to both groups. They will be advised to continue the medical treatment they have been using during the treatment program.

Procedure: Conventional Therapy Group

Interventions

In addition to the conventional treatment for 60 minutes in the RYT group, it was planned to perform robotic rehabilitation with a hand-finger robot \[Amadeo (Tyromotion, Graz, Austria)\] for 30 minutes, accompanied by a physiotherapist who is trained in the field of robotic rehabilitation and has at least 5 years of experience

Robot Assisted Therapy Group

An exercise program consisting of 45 minutes of range of motion exercises, strengthening exercises, balance exercises and neurophysiological exercises (Brunstroom exercises) and 15 minutes of NMES was planned, accompanied by a physiotherapist experienced for at least 5 years in stroke rehabilitation, in the conventional therapy group.

Conventional Therapy Group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral stroke
  • Between 4 weeks and 6 months after stroke
  • health status was suitable for rehabilitation
  • who could understand commands with a mini mental test score of 15 and above
  • who had Brunnstrom grade 3 and below (≤3).

You may not qualify if:

  • Patients with persistent upper extremity pain on the hemiplegic side (VAS\>40)
  • Patients with severe spasticity in the hand (MAS≥3)
  • Patients with contractures in the hand
  • Patients who had fractures or operations on the hemiplegic side in the last 6 months
  • Patients who received botulinum toxin injection to the upper extremity in the last 6 months
  • Patients with skin ulcers
  • Patients with brain stem or cerebellar lesions
  • Patients with neglect or apraxia
  • Patients with severe visual impairment and severe depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sevda Adar

Afyonkarahisar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • SEVDA ADAR

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

October 18, 2022

First Posted

November 1, 2022

Study Start

December 1, 2021

Primary Completion

May 1, 2023

Study Completion

June 1, 2023

Last Updated

July 20, 2023

Record last verified: 2023-07

Locations